Tag Archives: Rapid Dose Therapeutics

Burlington, Ontario–(Newsfile Corp. – March 5, 2026) – Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF), a Canadian biotechnology company specializing in oral thin film drug delivery technology, today announced the grant of a key patent for its QuickStrip™ Nicotine Bilayer Oral Film in partnership with Aavishkar Oral Strips. The …

Burlington, Ontario–(Newsfile Corp. – December 8, 2025) – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company“) announced today that it has extended the maturity date of its outstanding secured convertible notes (the “Notes“) previously issued on its private placement financing (the “Financing“) which closed in 2023. The Notes had a …

Burlington, Ontario–(Newsfile Corp. – July 3, 2025) – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company“) announces that it has agreed with its non-management directors (the “Directors“) to issue common shares (the “Debt Shares“) to such Directors in exchange for the cancellation of Director fees owing. Each of the …

Burlington, Ontario–(Newsfile Corp. – July 3, 2025) – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company“) announced today that as contemplated in the secured convertible notes (the “Notes“) previously issued on its private placement financing (the “Financing“), and consistent with prior quarters, the Company intends to issue common …

Burlington, Ontario–(Newsfile Corp. – May 26, 2025) – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”), a Canadian life sciences company specializing in innovative drug delivery solutions through its QuickStrip™ platform, today announced the filing of two critical patent applications in partnership with Aavishkar Oral Strips Pvt. Ltd. These …

Burlington, Ontario–(Newsfile Corp. – May 9, 2025) – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”) announces that it has agreed with certain of its creditors (the “Creditors”) to issue up to an aggregate of 2,500,000 common shares (the “Settlement Shares”) to such Creditors in exchange for the …

Burlington, Ontario–(Newsfile Corp. – April 8, 2025) –  Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”), a Canadian biotech Company providing proprietary oral delivery platform via sublingual thin film strip technology, is proud to announce an update to the ongoing collaboration project with the Faculty of Kinesiology & Health …

Burlington, Ontario–(Newsfile Corp. – April 3, 2025) – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”), a Canadian biotech Company providing proprietary oral delivery platform via sublingual thin film strip technology, is proud to announce its participation at major dental tradeshows across Canada to showcase and provide samples …

Burlington, Ontario–(Newsfile Corp. – April 1, 2025) – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”) announced today that as contemplated in the secured convertible notes (the “Notes”) previously issued on its private placement financing (the “Financing”), and consistent with prior quarters, the Company intends to issue common …

Burlington, Ontario–(Newsfile Corp. – February 18, 2025) – Rapid Dose Therapeutics Corp. (CSE: DOSE) (“RDT” or the “Company”) today announced that it plans to complete an equity private placement financing (the “Financing”) for up to $5,000,000 of gross proceeds, consisting of up to 20,833,333 common shares (the “Common Shares”) at …